NLM logo
66 results
  1. ... Disease, Bone Fragility, Glaucoma, Breast Cancer, Pancreatic Cancer, Acute Myeloid ... These documents include descriptions, collection forms, and scientific ...
  2. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    ... Healthcare Research and Quality ALT Alanine transaminase AML Acute myeloid ... Common terminology criteria for adverse events DCR Disease control rate ...
  3. ... related myelodysplastic syndrome (t-MDS) and therapy-related acute myeloid leukemia (t-AML). Therapy-related solid SNs. Therapy-Related ... related myelodysplastic syndrome (t-MDS) and therapy-related acute myeloid leukemia (t-AML) has been reported after treatment of ...
  4. ... initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – ... changes and risk of development of myelodysplastic syndrome—acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet. ...
  5. ... a diverse range of patients, including patients with acute myeloid leukemia [ 8 ] or those who are considering allogeneic stem ... and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia 18 (4): 809- ...
  6. ... Myeloid, Accelerated Phase Leukemia, Myeloid, Chronic-Phase Leukemia, Myeloid, Acute Leukemia, Basophilic, Acute Leukemia, Eosinophilic, Acute Leukemia, Erythroblastic, Acute ...
  7. ... ONCOGENE PROTEINS in PROSTATE CANCER; EWING'S SARCOMA; and ACUTE MYELOID LEUKEMIA. Tree locations: Trans-Activators D12.776.260.755. ...
  8. ... University of Texas MD Anderson Cancer Center Abstract: Acute Myeloid Leukemia (AML) is a very potent form of cancer ...
  9. NLM Digital Collections - PCORI Health Care Horizon Scanning System : high potential disruption report 
    Publication: Washington, DC : Patient-Centered Outcomes Research Institute, November 2020
    ... Hematopoietic Stem Cell Transplantation ....................................................................................................................... 45 Onureg to Treat Acute Myeloid Leukemia (Maintenance Setting) .................................... 48 Oraxol to Treat Locally Advanced ... for hematopoietic stem cell transplantationa Onureg to treat acute myeloid leukemia (maintenance setting)a Oraxol to treat locally advanced ...
  10. ... is 10% to 30% for hematologic malignancies (primarily acute myeloid leukemia) and 25% to 30% for nonhematologic malignancies (solid ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · next · last